Angiogenesis and antiangiogenic agents in non-small cell lung cancer-Reference-Cited by-同舟云学术

Angiogenesis and antiangiogenic agents in non-small cell lung cancer

Published:2001-12 Issue: Volume:34 Page:3-7
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Galligioni Enzo,Ferro Antonella

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference35 articles.

1. Angiogenesis and non-small cell lung cancer;Cox;Lung Cancer,2000

2. Antiangiogenesis for cancer therapy;Harris;Lancet,1997

3. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer;Koukourakis;Cancer Res.,2000

4. Angiogenesis and angiogenesis inhibitors in cancer;Giavazzi;Forum,1999

5. Antiangiogenesis and apoptosis as mediators of concomitant tumour resistance induced by Calu-6, a human lung carcinoma cell line, in nude mice;Bonfil;Oncol. Res.,1998

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer;Acta Biomaterialia;2018-08

2. Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice;Biochemical and Biophysical Research Communications;2015-08

3. Tumour vasculature targeting agents in hybrid/conjugate drugs;Angiogenesis;2013-03-31

4. VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population;Human Immunology;2013-01

5. Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma;Pharmacogenomics;2011-04